In addition, Lentinan can activate TXNIP-NLRP3 inflammasomes via the ASK1/p38 MAPK signaling pathway and cooperate with paclitaxel to treat non-small cell lung cancer (32). Here, MAP3K5 is linked to non-small cell lung carcinoma.